DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ultiva (Remifentanil) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Ultiva (Remifentanil) and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (90)
Death (5)
Life Threatening Events (21)

Reports by Reaction Type

Drug Rash With Eosinophilia and Systemic Symptoms (21)Premature Baby (11)Drug Withdrawal Syndrome Neonatal (8)Transient Tachypnoea of THE Newborn (8)Vomiting (8)Hyperreflexia (8)Irritability (8)Feeding Disorder (8)Anaphylactic Shock (7)Off Label Use (7)Maternal Exposure During Pregnancy (7)Premature Labour (7)

Below are a few examples of reports where side effects / adverse reactions may be related to Ultiva (Remifentanil). For a complete list or a specific selection of reports, please use the links above.

Possible Ultiva side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23

Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)

Reactions: Hyperaesthesia, Posterior Reversible Encephalopathy Syndrome, Hypertension

Drug(s) suspected as cause:
Ketamine HCL
    Dosage: 40mg administered intraoperatively

Ketamine HCL
    Dosage: 40mg administered intraoperatively

Ketamine HCL
    Indication: Induction of Anaesthesia

Ketamine HCL
    Indication: Prophylaxis

Ultiva
    Dosage: continuous infusion 0.15 microg/kg/hour
    Indication: Maintenance of Anaesthesia

Other drugs received by patient: Heparin; Sevoflurane; Sugammadex; Propofol; Rocuronium Bromide; Fentanyl; Fentanyl



Possible Ultiva side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-23

Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)

Reactions: Hyperaesthesia, Posterior Reversible Encephalopathy Syndrome, Hypertension

Drug(s) suspected as cause:
Ketamine HCL
    Dosage: 40mg administered intraoperatively

Ketamine HCL
    Indication: Prophylaxis

Ketamine HCL
    Dosage: 40mg administered intraoperatively

Ketamine HCL
    Indication: Induction of Anaesthesia

Ultiva
    Dosage: continuous infusion 0.15 microg/kg/hour
    Indication: Maintenance of Anaesthesia

Other drugs received by patient: Fentanyl; Rocuronium Bromide; Fentanyl; Heparin; Sevoflurane; Propofol; Sugammadex



Possible Ultiva side effects in

Reported by a individual with unspecified qualification from France on 2012-08-23

Patient:

Reactions: Cardio-Respiratory Arrest, Anaphylactic Shock, Circulatory Collapse

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Diprivan
    Dosage: 200 mg, once
    Indication: General Anaesthesia
    Start date: 2012-03-20
    End date: 2012-03-20

Rocuronium Bromide
    Dosage: 40 mg, once
    Indication: General Anaesthesia
    Start date: 2012-03-20
    End date: 2012-03-20

Ultiva
    Dosage: 50 ?g, once
    Indication: General Anaesthesia
    Start date: 2012-03-20
    End date: 2012-03-20



Possible Ultiva side effects in 37 year old female

Reported by a physician from Japan on 2012-08-21

Patient: 37 year old female

Reactions: Acidosis, Respiratory Depression, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal

Drug(s) suspected as cause:
Buprenorphine HCL
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28

Diprivan
    Dosage: unit dose unknown
    Indication: Sedation
    Start date: 2012-06-28
    End date: 2012-06-28

Ultiva
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28

Other drugs received by patient: Zonisamide; Phenytoin



Possible Ultiva side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-20

Patient: 67 year old female, weighing 47.0 kg (103.4 pounds)

Reactions: Posterior Reversible Encephalopathy Syndrome

Drug(s) suspected as cause:
Fentanyl
    Dosage: intermittent doses for maintenance

Fentanyl
    Indication: General Anaesthesia

Ketamine HCL
    Dosage: induction
    Indication: General Anaesthesia

Ketamine HCL
    Dosage: during anesthesia

Propofol

Propofol

Propofol

Propofol

Propofol
    Indication: General Anaesthesia

Sevoflurane
    Dosage: 1.3%
    Indication: General Anaesthesia

Ultiva
    Dosage: continuous infusion of 0.15 mcg/kg/h
    Indication: General Anaesthesia

Other drugs received by patient: Warfarin Sodium; Sugammadex; Benidipine; Cipralan; Heparin; Rocuronium Bromide; Warfarin Sodium



Possible Ultiva side effects in 37 year old female

Reported by a physician from Japan on 2012-08-17

Patient: 37 year old female

Reactions: Respiratory Depression, Acidosis, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal

Drug(s) suspected as cause:
Buprenorphine HCL
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28

Diprivan
    Dosage: unit dose unknown
    Indication: Sedation
    Start date: 2012-06-28
    End date: 2012-06-28

Ultiva
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28

Other drugs received by patient: Phenytoin; Zonisamide



Possible Ultiva side effects in 85 year old male

Reported by a physician from Canada on 2012-08-16

Patient: 85 year old male

Reactions: Drug Ineffective

Drug(s) suspected as cause:
Ultiva



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-08-08

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Transient Tachypnoea of THE Newborn, Vomiting, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Morphine HCL Elixir
    Indication: Foetal Exposure During Pregnancy

Phenobarbital TAB
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-10-27

Phenobarbital TAB
    Start date: 2011-10-27
    End date: 2011-10-31

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-07

Patient: female

Reactions: Off Label Use, Maternal Exposure During Pregnancy, Premature Labour, Drug Prescribing Error

Drug(s) suspected as cause:
Fentanyl Citrate
    Indication: General Anaesthesia
    Start date: 2011-10-25
    End date: 2011-10-25

Fentanyl-100
    Indication: Procedural Pain
    Start date: 2005-01-01
    End date: 2011-10-27

Fentanyl-100
    Indication: Pain
    Start date: 2005-01-01
    End date: 2011-10-27

Metoclopramide
    Administration route: Oral
    Indication: Uterine Contractions During Pregnancy

Morphine HCL Elixir
    Indication: Uterine Contractions During Pregnancy
    Start date: 2005-01-01

Ultiva
    Indication: General Anaesthesia
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in 37 year old female

Reported by a physician from Japan on 2012-08-03

Patient: 37 year old female

Reactions: Respiratory Depression, Acidosis, Delayed Recovery From Anaesthesia, Convulsion, Respiration Abnormal

Drug(s) suspected as cause:
Buprenorphine HCL
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28

Diprivan
    Dosage: unit dose unknown
    Indication: Sedation
    Start date: 2012-06-28
    End date: 2012-06-28

Ultiva
    Dosage: unit dose unknown
    Indication: Analgesic Therapy
    Start date: 2012-06-28
    End date: 2012-06-28



Possible Ultiva side effects in male

Reported by a physician from Japan on 2012-07-30

Patient: male, weighing 2.5 kg (5.4 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Vomiting, Transient Tachypnoea of THE Newborn, Premature Baby, Hyperreflexia, Drug Withdrawal Syndrome Neonatal, Irritability, Gamma-Glutamyltransferase Increased, Feeding Disorder, Analgesic Drug Level Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fentanyl Citrate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25

Fentanyl-100
    Indication: Foetal Exposure During Pregnancy
    Start date: 2005-01-01
    End date: 2011-10-27

Metoclopramide
    Indication: Foetal Exposure During Pregnancy

Morphine Hydrochloride
    Indication: Foetal Exposure During Pregnancy

Phenobarbital TAB
    Start date: 2011-10-27
    End date: 2011-10-31

Phenobarbital TAB
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-10-27
    End date: 2011-10-27

Ultiva
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in female

Reported by a physician from Japan on 2012-07-30

Patient: female

Reactions: Off Label Use, Maternal Exposure During Pregnancy, Drug Prescribing Error, Premature Labour

Drug(s) suspected as cause:
Fentanyl Citrate
    Indication: General Anaesthesia
    Start date: 2011-10-25
    End date: 2011-10-25

Fentanyl-100
    Indication: Pain
    Start date: 2005-01-01
    End date: 2011-10-27

Fentanyl-100
    Indication: Procedural Pain
    Start date: 2005-01-01
    End date: 2011-10-27

Metoclopramide
    Administration route: Oral
    Indication: Uterine Contractions During Pregnancy

Morphine Hydrochloride
    Indication: Uterine Contractions During Pregnancy
    Start date: 2005-01-01

Ultiva
    Indication: General Anaesthesia
    Start date: 2011-10-25
    End date: 2011-10-25



Possible Ultiva side effects in

Reported by a consumer/non-health professional from Japan on 2012-07-30

Patient:

Reactions: Pharyngeal Oedema, Cardio-Respiratory Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Diprivan
    Dosage: 100 mg, once
    Indication: Anaesthesia Procedure
    Start date: 2011-11-24
    End date: 2011-11-24

Rocuronium Bromide
    Indication: Neuromuscular Blocking Therapy
    Start date: 2011-11-24
    End date: 2011-11-24

Rocuronium Bromide
    Dosage: 50 mg, once
    Start date: 2011-11-24
    End date: 2011-11-24

Ultiva
    Dosage: perpetuation administering during 0.5mcg/kg/minute
    Indication: Analgesic Therapy
    Start date: 2011-11-24
    End date: 2011-11-24

Ultiva



Possible Ultiva side effects in

Reported by a physician from Japan on 2012-07-30

Patient:

Reactions: Piloerection, Anaphylactic Reaction, Blood Pressure Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Propofol
    Indication: Light Anaesthesia
    Start date: 2012-07-12
    End date: 2012-07-12

Rocuronium Bromide
    Start date: 2012-07-12
    End date: 2012-07-12

Ultiva
    Dosage: unk unk, once
    Indication: Analgesic Therapy
    Start date: 2012-07-12
    End date: 2012-07-12



Possible Ultiva side effects in

Reported by a pharmacist from Japan on 2012-07-25

Patient:

Reactions: Anaphylactic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Diprivan
    Indication: General Anaesthesia

Rocuronium Bromide

Ultiva



Possible Ultiva side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: female

Reactions: Maternal Drugs Affecting Foetus, Caesarean Section, Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal

Drug(s) suspected as cause:
Dopamine HCL
    Indication: Maternal Exposure During Pregnancy

Isoflurane
    Indication: Maternal Exposure During Pregnancy

Levothyroxine Sodium
    Indication: Maternal Exposure During Pregnancy

Ultiva
    Indication: Maternal Exposure During Pregnancy



Possible Ultiva side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: female

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal

Drug(s) suspected as cause:
Dopamine HCL
    Indication: Maternal Exposure During Pregnancy

Isoflurane
    Indication: Maternal Exposure During Pregnancy

Levothyroxine Sodium
    Indication: Maternal Exposure During Pregnancy

Ultiva
    Indication: Maternal Exposure During Pregnancy



Possible Ultiva side effects in 38 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20

Patient: 38 year old female

Reactions: Convulsions Local, Delayed Recovery From Anaesthesia

Drug(s) suspected as cause:
Buprenorphine HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-02
    End date: 2012-07-02

Ultiva
    Dosage: unknown dosage details
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Propofol



Possible Ultiva side effects in 62 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-12

Patient: 62 year old male

Reactions: Cardiac Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Bimatoprost and Timolol Maleate
    Dosage: unk
    Indication: Glaucoma
    Start date: 2000-01-01

Diprivan
    Dosage: 150 mg, unknown
    Indication: Anaesthesia
    Start date: 2011-06-06

Nimbex
    Dosage: 12 mg, single (iv, syringe pump)
    Indication: Anaesthesia
    Start date: 2011-06-06

Sufentanil Citrate
    Dosage: 15 units, unknown
    Indication: Anaesthesia
    Start date: 2011-06-06

Ultiva
    Dosage: 1.5 mg/kg/min
    Indication: Anaesthesia
    Start date: 2011-06-06

Other drugs received by patient: Trusopt



Possible Ultiva side effects in 16 year old male

Reported by a pharmacist from United States on 2012-07-12

Patient: 16 year old male, weighing 115.8 kg (254.8 pounds)

Reactions: Cardiac Arrest

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Diprivan
    Dosage: once iv { 1 hour
    Indication: Anaesthesia
    Start date: 2012-07-02
    End date: 2012-07-02

Ultiva
    Dosage: once iv { 1 hour
    Indication: Anaesthesia
    Start date: 2012-07-02
    End date: 2012-07-02



Possible Ultiva side effects in

Reported by a physician from Japan on 2012-07-06

Patient: , weighing 2.3 kg (5.1 pounds)

Reactions: Premature Baby, Foetal Exposure During Pregnancy, Heart Sounds Abnormal

Drug(s) suspected as cause:
Dopamine HCL
    Indication: Maternal Exposure Timing Unspecified

Isoflurane
    Indication: Maternal Exposure Timing Unspecified

Levothyroxine Sodium
    Indication: Maternal Exposure Timing Unspecified

Ultiva
    Indication: Maternal Exposure Timing Unspecified



Possible Ultiva side effects in 17 year old male

Reported by a physician from Japan on 2012-07-02

Patient: 17 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash

Drug(s) suspected as cause:
Atropine
    Start date: 2011-06-20
    End date: 2011-06-20

Cefazolin Sodium
    Start date: 2011-06-20
    End date: 2011-06-20

Diprivan
    Dosage: 10mg/ml, 1200mg/hr
    Indication: General Anaesthesia
    Start date: 2011-06-20

Diprivan
    Start date: 2011-06-20
    End date: 2011-06-20

Fentanyl
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Fentanyl
    Start date: 2011-06-20
    End date: 2011-06-20

Flurbiprofen
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Isotonic Sodium Chloride Solution
    Start date: 2011-06-20
    End date: 2011-06-20

Mepivacaine HCL
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Mepivacaine HCL
    Dosage: 20mg/ml

Physio 140
    Start date: 2011-06-20
    End date: 2011-06-20

Ropivacaine Hydrochloride
    Dosage: 0.375%, 4 ml/hr continuously
    Start date: 2011-06-20
    End date: 2011-06-20

Ropivacaine Hydrochloride
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Salinhes
    Start date: 2011-06-20
    End date: 2011-06-20

Ultiva
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Ultiva
    Dosage: 0.5mg/hr
    Start date: 2011-06-20
    End date: 2011-06-20

Xylocaine
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Other drugs received by patient: Relaxin; Polaramine; Neophyllin Injection; Hydrocortisone Sodium Succinate; Rocuronium Bromide



Possible Ultiva side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-21

Patient: male, weighing 4.5 kg (9.9 pounds)

Reactions: Respiratory Rate Decreased, Incorrect Dose Administered, Accidental Overdose

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Propofol
    Indication: General Anaesthesia

Ultiva
    Dosage: dose unit:5.4
    Indication: General Anaesthesia

Other drugs received by patient: Sodium Chloride



Possible Ultiva side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-18

Patient: 59 year old male

Reactions: Tachycardia, Hypotension, Bronchospasm

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Propofol
    Dosage: iv
    Indication: Induction of Anaesthesia
    Start date: 2012-02-20
    End date: 2012-02-20

Rocuronium Bromide
    Dosage: iv
    Indication: Induction of Anaesthesia
    Start date: 2012-02-20
    End date: 2012-02-20

Ultiva
    Dosage: iv
    Indication: Induction of Anaesthesia
    Start date: 2012-02-20
    End date: 2012-02-20



Possible Ultiva side effects in 48 year old female

Reported by a individual with unspecified qualification from France on 2012-06-14

Patient: 48 year old female

Reactions: Urticaria, Rash, Tryptase Increased

Drug(s) suspected as cause:
Propofol
    Dosage: 1 df; once; iv
    Indication: General Anaesthesia
    Start date: 2012-02-08
    End date: 2012-02-08

Rocuronium Bromide
    Dosage: 1 df; once; iv
    Indication: General Anaesthesia
    Start date: 2012-02-08
    End date: 2012-02-08

Ultiva
    Dosage: 1 df; once; iv
    Indication: General Anaesthesia
    Start date: 2012-02-08
    End date: 2012-02-08



Possible Ultiva side effects in 68 year old male

Reported by a physician from Japan on 2012-06-12

Patient: 68 year old male

Reactions: Pharyngeal Oedema, Respiratory Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Diprivan
    Dosage: 100 mg; once; iv
    Indication: Anaesthesia Procedure
    Start date: 2011-11-24
    End date: 2011-11-24

Rocuronium Bromide
    Dosage: 50 mg; once; iv
    Indication: Neuromuscular Blocking Therapy
    Start date: 2011-11-24
    End date: 2011-11-24

Ultiva
    Dosage: 0.5 mcg/kg; iv
    Indication: Analgesic Therapy
    Start date: 2011-11-24
    End date: 2011-11-24



Possible Ultiva side effects in 81 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-07

Patient: 81 year old male

Reactions: Tongue Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Perindopril Erbumine
    Dosage: oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2012-04-03
    End date: 2012-04-03

Propofol
    Dosage: intravenous (not otherwise specified)
    Indication: Induction of Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Rocuronium Bromide
    Dosage: intravenous (not otherwise specified)
    Indication: Induction and Maintenance of Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Ultiva
    Dosage: intravenous (not otherwise specified)
    Indication: Induction and Maintenance of Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Other drugs received by patient: Perfalgan (Paracetamol) (Paracetamol)



Possible Ultiva side effects in 17 year old male

Reported by a physician from Japan on 2012-06-04

Patient: 17 year old male, weighing 70.0 kg (154.0 pounds)

Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash

Drug(s) suspected as cause:
Atropine
    Start date: 2011-06-20
    End date: 2011-06-20

Cefazolin Sodium
    Start date: 2011-06-20
    End date: 2011-06-20

Diprivan
    Start date: 2011-06-20
    End date: 2011-06-20

Diprivan
    Dosage: 10mg/ml, 1200mg/hr
    Indication: General Anaesthesia
    Start date: 2011-06-20

Fentanyl
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Fentanyl
    Start date: 2011-06-20
    End date: 2011-06-20

Flurbiprofen
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Isotonic Sodium Chloride Solution
    Start date: 2011-06-20
    End date: 2011-06-20

Mepivacaine HCL
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Mepivacaine HCL
    Dosage: 20mg/ml

Physio 140
    Start date: 2011-06-20
    End date: 2011-06-20

Ropivacaine Hydrochloride
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Ropivacaine Hydrochloride
    Dosage: 0.375%, 4 ml/hr continuously
    Start date: 2011-06-20
    End date: 2011-06-20

Salinhes
    Start date: 2011-06-20
    End date: 2011-06-20

Ultiva
    Dosage: 0.5mg/hr
    Start date: 2011-06-20
    End date: 2011-06-20

Ultiva
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Xylocaine
    Indication: Analgesic Therapy
    Start date: 2011-06-20
    End date: 2011-06-20

Other drugs received by patient: Rocuronium Bromide; Hydrocortisone Sodium Succinate; Neophyllin Injection; Relaxin; Polaramine



Possible Ultiva side effects in 81 year old male

Reported by a physician from Italy on 2012-05-31

Patient: 81 year old male

Reactions: Tongue Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Perindopril Erbumine
    Dosage: 5 mg; qd; po
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01
    End date: 2012-04-03

Propofol
    Dosage: 130 mcg; once; iv
    Indication: Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Rocuronium Bromide
    Dosage: 40 mg; once; iv
    Indication: Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Ultiva
    Dosage: 2 mg; once; iv
    Indication: Anaesthesia
    Start date: 2012-04-03
    End date: 2012-04-03

Other drugs received by patient: Acetaminophen



Possible Ultiva side effects in 17 year old male

Reported by a physician from Japan on 2012-05-21

Patient: 17 year old male

Reactions: Airway Peak Pressure Increased, Generalised Erythema, Mechanical Ventilation Complication, Rash

Drug(s) suspected as cause:
Carbocain
    Dosage: 20mg/ml
    Indication: Pain Management

Cefazolin Sodium
    Start date: 2011-06-20
    End date: 2011-06-20

Fentanyl-100
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Flurbiprofen
    Dosage: 50 mg
    Indication: Pain Management
    Start date: 2011-06-20
    End date: 2011-06-20

Propofol
    Dosage: 10mg/ml, total dose of was 2161 mg (bolus administration 200mg, continuous administration 1061mg)
    Start date: 2011-06-20
    End date: 2011-06-20

Propofol
    Dosage: 10mg/ml, 1200mg/hr
    Indication: General Anaesthesia
    Start date: 2011-06-20

Propofol
    Dosage: 10mg/ml, 360mg/hr
    Start date: 2011-06-20

Propofol
    Dosage: 10mg/ml, with target of blood concentration of 300mg/hr (after 14:15) 280mg/hr (after 15:15)
    Start date: 2011-06-20

Propofol
    Dosage: 10mg/ml, with target of blood concentration of 350mg/hr (after 15:35) and 250 mg/hr (after 16:45)
    Start date: 2011-06-20
    End date: 2011-06-20

Ropivacaine Hydrochloride
    Dosage: 0.375%, 4 ml/hr continuously
    Indication: Pain Management
    Start date: 2011-06-20
    End date: 2011-06-20

Ultiva
    Dosage: 0.2mg/hr
    Start date: 2011-06-20

Ultiva
    Dosage: 0.5mg/hr
    Indication: Anaesthesia Procedure
    Start date: 2011-06-20
    End date: 2011-06-20

Other drugs received by patient: Xylocaine; NI; Polaramine; Hydrocortisone Sodium Succinate; Salinhes; Rocuronium Bromide; Neophyllin Injection; Atropine; Physio 140; Relaxin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017